Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories long-Lived Assets — United States ($M) ($M)
Postgres DB segment_values + Form 10-K Geographic Footnote
Latest, FY2025
11,900
Period ended Dec 31, 2025
Change on a year earlier
+15.5%
10,300 in FY2024
History
12 years
Since FY2014
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-Lived Assets — United States ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,900 | +15.5% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 10,300 | +15.7% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 8,900 | +15.6% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 7,700 | +13.2% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 6,800 | +11.5% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 6,100 | +19.6% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 5,100 | +18.6% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 4,300 | -4.4% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 4,500 | +45.2% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 3,100 | 0.0% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 3,100 | 0.0% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 3,100 | – | Form 10-K (filed 2016-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Long-Lived Assets — United States ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-lla-us
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.